Patent · US Active

Protein kinase C inhibitors and uses thereof

US9149475B2 · kind B2 · utility

4Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2012
Grant dateOct 6, 2015
Priority date
Expiry dateMay 30, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.